ALPINE IMMUNE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alpine Immune Sciences, Inc. - ALPNBusiness Wire • 04/26/24
Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and OlderBusiness Wire • 04/26/24
Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.The Motley Fool • 04/24/24
VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETESPRNewsWire • 04/23/24
If You'd Invested $10,000 in Vertex Pharmaceuticals 5 Years Ago, Here's How Much You'd Have TodayThe Motley Fool • 04/22/24
Looking for Once-in-a-Generation Investment Opportunities? Here Are 3 Magnificent Stocks to Buy Right NowThe Motley Fool • 04/22/24
Vertex Announces Advancements of Suzetrigine (VX-548) in Acute and Neuropathic PainBusiness Wire • 04/18/24